Lydall Inc (LDL.N) Key Developments | Reuters.com
Edition:
United States

Lydall Inc (LDL.N)

LDL.N on New York Stock Exchange

37.36USD
2:55pm EDT
Change (% chg)

$0.18 (+0.48%)
Prev Close
$37.18
Open
$37.45
Day's High
$37.48
Day's Low
$37.09
Volume
6,694
Avg. Vol
26,558
52-wk High
$40.22
52-wk Low
$25.30

Latest Key Developments (Source: Significant Developments)

Lydall announces CFO departure
Monday, 13 Apr 2015 04:09pm EDT 

Lydall:Says Robert K. Julian, Executive Vice President and Chief Financial Officer, has resigned his position with the Company to pursue another career opportunity.Julian plans to continue as Chief Financial Officer of Company through May 1 to facilitate an orderly transition of his responsibilities.Company intends to initiate a search process for the Chief Financial Officer position.  Full Article

Lydall announces divestiture of Charter Medical to Fenner PLC's subsidiary
Friday, 30 Jan 2015 12:41pm EST 

LYDALL, INC:Completes sale of Charter Medical, Ltd., a designer and manufacturer of specialty single-use products utilized in blood management, blood filtration and biopharmaceutical applications for the collection, processing, and storage of biological fluids.Charter Medical was acquired by a subsidiary of Fenner PLC for a purchase price of $29.9 million.  Full Article

Lydall Inc gives Q3, H2 2014 revenue guidance
Thursday, 31 Jul 2014 07:00am EDT 

Lydall Inc:Expect sales growth in the Q3, H2 2014 to be less robust than the H1 2014 due to timing of customer orders, typical customer plant shut-downs in North America and Europe as well as seasonality that normally occurs in some of segments.Expect lower organic sales growth in the second half compared to the H1 2014.  Full Article

BRIEF-Lydall Inc reports Q1 earnings per share $0.54

* Lydall announces financial results for the first quarter ended march 31, 2016